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Background
Genetic testing is commonly used in the management of
patients with hypertrophic cardiomyopathy (HCM).
Some studies suggest patients who test positive for
known markers have a greater risk for adverse out-
comes. In addition, the presence of late gadolinium
enhancement (LGE) on cardiac MRI (cMRI) has also
been associated with poorer outcomes and prognosis.
Whether positive genetic testing is a predictor of LGE
on cMRI is unknown.
Methods
All patients referred to the Lehigh Valley Health Network
HCM center who had received genetic testing between
December 2009 and December 2012 and a cMRI were
included. Clinical data (including associated symptoms)
and imaging data were recorded for all patients. Image
data was reviewed independently and blinded to clinical
data. Characterization of LGE was defined as present or
absent. LGE present on cMRI was further investigated and
measured for mass and standardized to the mass of the
left ventricle (LGEi). Genetic testing was considered posi-
tive if a mutation was identified or negative if no mutation
was detected.
Results
63 patients (mean age 51.4 ± 18 years; 42.9% male, gene
positive 52.4%) were included in which 35 received
cMRI. LGE was defined as present in 14 patients, 9 of
which had received positive genetic testing. Fisher’s
exact test resulted in a p-value of 0.217. Sensitivity and
specificity for positive genetic testing showing LGE on
cMRI was 45% and 66.7% respectively with a PPV of
64.3% and NPV of 47.6%. In those patients who were
positive for LGE, LGEi appears to be trending higher in
patients with positive genetic testing compared to those
with negative genetic testing 4.0 ± 3.1% and 3.5 ± 2.1%
respectively (p = 0.378).
Conclusions
There was no significant indicator that patients whom
tested positive for genes known to cause HCM showed
increased rates of LGE on cMRI. However, there was a
higher prevalence of LGE in gene positive patients that
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